459 related articles for article (PubMed ID: 33358717)
1. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Cornara S; Somaschini A; Demarchi A; Galazzi M; Puccio S; Montalto C; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):608-614. PubMed ID: 33358717
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Kajana V; Cornara S; Somaschini A; Demarchi A; Galazzi M; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2140-2143. PubMed ID: 34039505
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Crimi G; Raineri C; Pica S; Ruffinazzi M; Gianni U; Repetto A; Ferlini M; Marinoni B; Leonardi S; De Servi S; Oltrona Visconti L; De Ferrari GM; Ferrario M
J Cardiovasc Med (Hagerstown); 2018 May; 19(5):240-246. PubMed ID: 29470249
[TBL] [Abstract][Full Text] [Related]
4. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction.
Her AY; Cho KI; Singh GB; An DS; Jeong YH; Koo BK; Shin ES
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1445-1454. PubMed ID: 28555389
[TBL] [Abstract][Full Text] [Related]
5. Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience.
Zuin M; Rigatelli G; Picariello C; dell'Avvocata F; Marcantoni L; Pastore G; Carraro M; Nanjundappa A; Faggian G; Roncon L
Cardiovasc Revasc Med; 2017 Dec; 18(8):565-571. PubMed ID: 28529092
[TBL] [Abstract][Full Text] [Related]
6. Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction.
Oh PC; Eom YS; Moon J; Jang HJ; Kim TH; Suh J; Kong MG; Park SD; Kwon SW; Suh SY; Lee K; Han SH; Ahn T; Kang WC
BMC Cardiovasc Disord; 2020 Nov; 20(1):486. PubMed ID: 33208092
[TBL] [Abstract][Full Text] [Related]
7. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Machado GP; Araujo GN; Carpes CK; Lech M; Mariani S; Valle FH; Bergoli LCC; Gonçalves SC; Wainstein RV; Wainstein MV
Atherosclerosis; 2018 Jul; 274():212-217. PubMed ID: 29803159
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.
Zhang S; Diao J; Qi C; Jin J; Li L; Gao X; Gong L; Wu W
BMC Cardiovasc Disord; 2018 May; 18(1):75. PubMed ID: 29716535
[TBL] [Abstract][Full Text] [Related]
9. High cystatin C levels predict long-term mortality in patients with ST-segment elevation myocardial infarction undergoing late percutaneous coronary intervention: A retrospective study.
Chen Y; Fan Y; Men M; Shen G; Ma A
Clin Cardiol; 2019 May; 42(5):572-578. PubMed ID: 30907012
[TBL] [Abstract][Full Text] [Related]
10. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
[TBL] [Abstract][Full Text] [Related]
11. Relationship of serum uric acid and Killip class on mortality after acute ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.
Liu CW; Liao PC; Chen KC; Chiu YW; Liu YH; Ke SR; Wu YW
Int J Cardiol; 2017 Jan; 226():26-33. PubMed ID: 27780079
[TBL] [Abstract][Full Text] [Related]
12. The relationship between hyperuricemia and contrast-induced acute kidney injury undergoing primary percutaneous coronary intervention: secondary analysis protocol for the ATTEMPT RESCIND-1 study.
Guo W; Song F; Chen S; Zhang L; Sun G; Liu J; Chen J; Liu Y; Tan N;
Trials; 2020 Jun; 21(1):567. PubMed ID: 32580757
[TBL] [Abstract][Full Text] [Related]
13. Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality.
Del Turco S; Basta G; De Caterina AR; Sbrana S; Paradossi U; Taddei A; Trianni G; Ravani M; Palmieri C; Berti S; Mazzone A
Int J Cardiol; 2019 Sep; 290():34-39. PubMed ID: 31079969
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Wanamaker BL; Seth MM; Sukul D; Dixon SR; Bhatt DL; Madder RD; Rumsfeld JS; Gurm HS
J Am Heart Assoc; 2019 Oct; 8(19):e013551. PubMed ID: 31547767
[TBL] [Abstract][Full Text] [Related]
15. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction.
Çınar T; Çağdaş M; Rencüzoğulları İ; Karakoyun S; Karabağ Y; Yesin M; Sadioğlu Çağdaş Ö; Tanboğa Hİ
Scand Cardiovasc J; 2019 Apr; 53(2):83-90. PubMed ID: 30835559
[TBL] [Abstract][Full Text] [Related]
16. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
[TBL] [Abstract][Full Text] [Related]
17. Hyperuricemia is Associated With 2- and 5-Year Adverse Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Tang XF; He C; Zhu P; Zhang C; Song Y; Xu JJ; Yao Y; Xu N; Jiang P; Jiang L; Gao Z; Zhao XY; Gao LJ; Song L; Yang YJ; Gao RL; Xu B; Yuan JQ
Front Endocrinol (Lausanne); 2022; 13():852247. PubMed ID: 35663308
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.
Basar N; Sen N; Ozcan F; Erden G; Kanat S; Sokmen E; Isleyen A; Yuzgecer H; Ozlu MF; Yildirimkaya M; Maden O; Covic A; Johnson RJ; Kanbay M
J Investig Med; 2011 Aug; 59(6):931-7. PubMed ID: 21415772
[TBL] [Abstract][Full Text] [Related]
19. Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Mandurino-Mirizzi A; Demarchi A; Ruffinazzi M; Cornara S; Somaschini A; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona Visconti L; De Ferrari GM
J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):337-339. PubMed ID: 31977536
[No Abstract] [Full Text] [Related]
20. Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.
Leibundgut G; Gick M; Morel O; Ferenc M; Werner KD; Comberg T; Kienzle RP; Buettner HJ; Neumann FJ
Clin Res Cardiol; 2016 May; 105(5):432-40. PubMed ID: 26563201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
